Cost 2022
Top Research Directions
The 4 research directions with Cost 2022 papers, ranked by paper count, next to 2020. Share is the fraction of the edition’s papers in the direction.
| # | Direction | 2022 | 2020 | Share 2022 | Share 2020 | 2020 rank |
|---|---|---|---|---|---|---|
| 1 | Evaluating Clinical Outcomes Using Historical Patient Cohorts | 1 | 0 | 100.0% | 0.0% | — |
| 2 | Isolating Independent Risk Factors via Multivariable Logistic Regression | 1 | 0 | 100.0% | 0.0% | — |
| 3 | The Clinical Granularity Gap in Administrative Health Data | 1 | 0 | 100.0% | 0.0% | — |
| 4 | The Geography of Healthcare Access and Infrastructure Inequity | 1 | 0 | 100.0% | 0.0% | — |
Download all directions as CSV
Institutions
Institutions credited by Cost 2022 papers: a paper credits every institution named in its affiliations, once. 2 institutions share 1 credited papers.
| # | Institution | Papers | Share | 2020 | 2020 rank |
|---|---|---|---|---|---|
| 1 | 044r51149 | 1 | 100.0% | 0 | — |
| 2 | Harbin Medical University | 1 | 100.0% | 0 | — |
Download all institutions as CSV
About this data
Papers. Cost 2022 lists 1 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.
Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers. Comparisons with 2020 use shares, since the edition went from 1 to 1 papers.
Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 1 of 1 papers (100.0%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.
Data. Counts come from Lacuna’s data build of 2026-11-19 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “Cost 2022”, https://lacuna.tiptreesystems.com/venue/cost/2022.
Papers
| Title |
|---|
| The influence of cross-regional medical treatment on total medical expenses, medical insurance payments, and out-of-pocket expenses of patients with malignant tumors in Chinese low-income areas |